KLRK1 and neoplasm: For example, the NKG2D-IL-15 fusion protein needs to bind to MICA on the surface of tumor cells, and this binding hinders the binding of NKG2D on NK cells to MICA on tumor cells, which is unfavorable for the activation of NK cells.